Alpha 2.0
Login Register
» Authors » Neil Gupta

Neil Gupta

Explore the profile of Neil Gupta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 231
Citations 3852
Followers 0
Related Specialties
Gastroenterology
Radiology
Pharmacology
Top 10 Co-Authors
Prateek Sharma
Ajay Bansal
Amit Rastogi
Srinivas Gaddam
Gene Bukhman
Prashanth Vennalaganti
Sachin B Wani
Sachin Wani
Sabin Nsanzimana
Mandeep Singh
Published In
Gastrointest Endosc
Gastroenterology
Clin Gastroenterol Hepatol
PLoS One
Lancet Gastroenterol Hepatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Implementation of an infection prevention and control response strategy to combat the Sudan Virus Disease outbreak in an urban setting, the Kampala Metropolitan area, Uganda, 2022
Nanyondo S, Nakato S, Franklin J, Kwiringira A, Malikisi M, Kesande M, et al.
BMC Infect Dis . 2025 Mar; 25(1):317. PMID: 40050780
Background: In October 2022, the Uganda Ministry of Health (MoH) confirmed the first case of a Sudan Virus Disease (SVD) outbreak in the Kampala Metropolitan area (KMA). A multicomponent infection...
2.
Key actions to improve linkage to care for pregnant and postpartum women with hepatitis C
Gupta N, Hiebert L, Ward J
Am J Obstet Gynecol . 2024 Oct; 232(3):e120. PMID: 39428031
No abstract available.
3.
Estimating the Prevalence of Injection Drug Use Among Acute Hepatitis C Cases From a National Surveillance System: Application of Random Forest-Based Multiple Imputation
Yin S, Ly K, Barker L, Bixler D, Thompson N, Gupta N
J Public Health Manag Pract . 2024 Jul; 30(5):733-743. PMID: 39041767
Background: Injection drug use (IDU) is a major contributor to the syndemic of viral hepatitis, human immunodeficiency virus, and drug overdose. However, information on IDU is frequently missing in national...
4.
Medicaid Expansion and Restriction Policies for Hepatitis C Treatment
Furukawa N, Ingber S, Symum H, Rapposelli K, Teshale E, Thompson W, et al.
JAMA Netw Open . 2024 Jul; 7(7):e2422406. PMID: 39012632
Importance: Hepatitis C can be cured with direct-acting antivirals (DAAs), but Medicaid programs have implemented fibrosis, sobriety, and prescriber restrictions to control costs. Although restrictions are easing, understanding their association...
5.
Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice
Gupta N, Hiebert L, Saseetharran A, Chappell C, El-Sayed M, Hamid S, et al.
Am J Obstet Gynecol . 2024 Jul; 231(4):377-385. PMID: 38960017
There is an increasing burden of hepatitis C virus among persons of reproductive age, including pregnant and breastfeeding women, in many regions worldwide. Routine health services during pregnancy present a...
6.
Correction: Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable Disease
Klassen S, Okello E, Ferrer J, Alizadeh F, Barango P, Chillo P, et al.
Glob Heart . 2024 Jul; 19(1):54. PMID: 38947254
[This corrects the article DOI: 10.5334/gh.1313.].
7.
Barriers to longitudinal follow-up for hepatitis B treatment in rural Sierra Leone: A mixed methods study of retention in care
Lebbie W, Allan-Blitz L, Nyama E, Swaray M, Lavalie D, Mhango M, et al.
Clin Liver Dis (Hoboken) . 2024 Jun; 23(1):e0225. PMID: 38831767
HBV disproportionately affects resource-limited settings, and retaining patients in longitudinal care remains challenging. We conducted a mixed methods investigation to understand the causes of losses to follow-up within an HBV...
8.
Estimating hepatitis C prevalence in the United States, 2017-2020
Hall E, Bradley H, Barker L, Lewis K, Shealey J, Valverde E, et al.
Hepatology . 2024 May; 81(2):625-636. PMID: 38739849
Background And Aims: The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of HCV infection. By accounting for populations inadequately represented in NHANES, we created 2 models...
9.
Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable Disease
Klassen S, Okello E, Ferrer J, Alizadeh F, Barango P, Chillo P, et al.
Glob Heart . 2024 Mar; 19(1):33. PMID: 38549727
Rheumatic and congenital heart disease, cardiomyopathies, and hypertensive heart disease are major causes of suffering and death in low- and lower middle-income countries (LLMICs), where the world's poorest billion people...
10.
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers
Gupta N, Swindells S, Scarsi K, Furl R, Thomas D, Weld E, et al.
J Viral Hepat . 2024 Mar; 31(5):221-232. PMID: 38545826
Long-acting technologies (LATs) for hepatitis C virus (HCV) are under development as a strategy to improve linkage to care, treatment adherence and outcomes. We conducted a survey of HCV treatment...